Michele Miragoli1, Jose L Sanchez-Alonso2, Anamika Bhargava3, Peter T Wright2, Markus Sikkel2, Sophie Schobesberger2, Ivan Diakonov2, Pavel Novak4, Alessandra Castaldi5, Paola Cattaneo5, Alexander R Lyon6, Max J Lab7, Julia Gorelik8. 1. National Heart and Lung Institute, Imperial College London, 4th floor, Imperial Centre for Translational and Experimental Medicine, Hammersmith Campus Du Cane Road, London W12 0NN, UK; Humanitas Clinical and Research Center, via Manzoni 56, Rozzano, 20090 Milan, Italy; Center of Excellence for Toxicological Research, INAIL exISPESL, University of Parma, via Gramsci 14, 43126 Parma, Italy. Electronic address: michele.miragoli@humanitasresearch.it. 2. National Heart and Lung Institute, Imperial College London, 4th floor, Imperial Centre for Translational and Experimental Medicine, Hammersmith Campus Du Cane Road, London W12 0NN, UK. 3. National Heart and Lung Institute, Imperial College London, 4th floor, Imperial Centre for Translational and Experimental Medicine, Hammersmith Campus Du Cane Road, London W12 0NN, UK; Department of Biotechnology, Indian Institute of Technology Hyderabad, Ordnance Factory Estate, Yeddumailaram, 502205 Telangana, India. 4. National Heart and Lung Institute, Imperial College London, 4th floor, Imperial Centre for Translational and Experimental Medicine, Hammersmith Campus Du Cane Road, London W12 0NN, UK; School of Engineering and Materials Science, Queen Mary, University of London, Mile End Road, London E1 4NS, UK. 5. Humanitas Clinical and Research Center, via Manzoni 56, Rozzano, 20090 Milan, Italy. 6. National Heart and Lung Institute, Imperial College London, 4th floor, Imperial Centre for Translational and Experimental Medicine, Hammersmith Campus Du Cane Road, London W12 0NN, UK; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London SW36NP, UK. 7. National Heart and Lung Institute, Imperial College London, 4th floor, Imperial Centre for Translational and Experimental Medicine, Hammersmith Campus Du Cane Road, London W12 0NN, UK. Electronic address: m.lab@imperial.ac.uk. 8. National Heart and Lung Institute, Imperial College London, 4th floor, Imperial Centre for Translational and Experimental Medicine, Hammersmith Campus Du Cane Road, London W12 0NN, UK. Electronic address: j.gorelik@imperial.ac.uk.
Abstract
Arrhythmogenesis during heart failure is a major clinical problem. Regional electrical gradients produce arrhythmias, and cellular ionic transmembrane gradients are its originators. We investigated whether the nanoscale mechanosensitive properties of cardiomyocytes from failing hearts have a bearing upon the initiation of abnormal electrical activity. Hydrojets through a nanopipette indent specific locations on the sarcolemma and initiate intracellular calcium release in both healthy and heart failure cardiomyocytes, as well as in human failing cardiomyocytes. In healthy cells, calcium is locally confined, whereas in failing cardiomyocytes, calcium propagates. Heart failure progressively stiffens the membrane and displaces sub-sarcolemmal mitochondria. Colchicine in healthy cells mimics the failing condition by stiffening the cells, disrupting microtubules, shifting mitochondria, and causing calcium release. Uncoupling the mitochondrial proton gradient abolished calcium initiation in both failing and colchicine-treated cells. We propose the disruption of microtubule-dependent mitochondrial mechanosensor microdomains as a mechanism for abnormal calcium release in failing heart.
Arrhythmogenesis during heart failure is a major clinical problem. Regional electrical gradients produce arrhythmias, and cellular ionic transmembrane gradients are its originators. We investigated whether the nanoscale mechanosensitive properties of cardiomyocytes from failing hearts have a bearing upon the initiation of abnormal electrical activity. Hydrojets through a nanopipette indent specific locations on the sarcolemma and initiate intracellular calcium release in both healthy and heart failure cardiomyocytes, as well as in human failing cardiomyocytes. In healthy cells, calcium is locally confined, whereas in failing cardiomyocytes, calcium propagates. Heart failure progressively stiffens the membrane and displaces sub-sarcolemmal mitochondria. Colchicine in healthy cells mimics the failing condition by stiffening the cells, disrupting microtubules, shifting mitochondria, and causing calcium release. Uncoupling the mitochondrial proton gradient abolished calcium initiation in both failing and colchicine-treated cells. We propose the disruption of microtubule-dependent mitochondrial mechanosensor microdomains as a mechanism for abnormal calcium release in failing heart.
Pump failure and sudden cardiac death remain a major clinical problem despite conventional therapies. Altered mechanosensitivity initiates electrical instability and arrhythmia in heart failure (Kiseleva et al., 2000). Whereas pro-arrhythmic mechanoelectric transduction has been extensively investigated in intact hearts in situ, isolated hearts, and in isolated cellular preparations, the initial subcellular mechanisms required for signal transduction and its initiation remain elusive (Lammerding et al., 2004). Recent attention has focused upon different sarcomeric components (Kim et al., 1999), and in addition to force generation, several sarcomeric proteins were found to provide mechanosensing and/or signaling functions (Borg et al., 2000, Knöll et al., 2002). Mutations in these sarcomeric or Z-disk complex proteins cause abnormal intracellular Ca2+ responses (Knöll et al., 2002).During heart failure, the cytoskeletal scaffold remodels, and this may also disturb the normal regulation of mechanosensation (Janmey and Miller, 2011). Loss of appropriate mechanical feedback control may contribute to the development of heart failure. The structural remodeling that occurs during heart failure involves the cell membrane (loss of T-tubules; Lyon et al., 2009), intercalated disks (Ferreira-Cornwell et al., 2002), and sub-membrane microdomains involving ryanodine receptors (RyRs) and the sarcoplasmic reticulum (Dobrev and Wehrens, 2014). Importantly, mitochondria change their subcellular location (Piquereau et al., 2013, Rosca et al., 2013) and the inter-fibrillar mitochondria alignment is altered early following myocardial infarction (Dague et al., 2014). Regular alignment of mitochondria and the dyad plays a pivotal role in the homeostasis of excitation-contraction coupling (Chen et al., 2012, Kohlhaas and Maack, 2013, Lu et al., 2013) and intracellular calcium handling (Belmonte and Morad, 2008b). However, little is known about the possible role of mitochondria remodeling in mechanoelectric transduction-induced arrhythmia. This reflects the inability of many conventional technologies to selectively and mechanically activate or investigate mitochondrial involvement within a single sarcolemmal microdomain. Here, we have employed scanning ion conductance microscopy (SICM) and surface confocal SICM to resolve cellular topography and mitochondria localization.We applied pressure via the SICM nanopipette with nanometer precision to investigate the subcellular mechanisms underlying mechanically induced calcium release in heart failure (Figure 1). Hydrojets targeting structurally regular Z-grooves in healthy cardiomyocytes caused mechanically induced intracellular calcium release (MiCai) events, which were spatially confined. By contrast, MiCai propagated throughout the cell in failing cardiomyocytes with irregular Z-grooves. We found that the likelihood of producing propagating MiCai correlated with the degree of mitochondrial derangement within the dyad as well as with a decrease in membrane compliance at the point of applied mechanical force. Having excluded mechanosensitive ion channels and actin filaments as the mechanosensing substrates, we observed that propagating MiCai could be simulated by disrupting microtubules in healthy cardiomyocytes, which are responsible for maintaining sub-sarcolemmal mitochondrial positions (Saetersdal et al., 1990). Uncoupling the mitochondrial proton gradient abolishes MiCai propagation. It appears that microtubules associated with mitochondria may represent a signaling microdomain that responds to mechanical stimulation of the sarcolemma. This study suggests that microtubular and mitochondrial derangement play pivotal roles in the initiation of abnormal calcium release during progression toward heart failure and provides an additional mechanism for non-action potential-mediated intracellular calcium release, which could lead to triggered activity and arrhythmias.
Figure 1
Schematic Representation of the Experimental Protocol
(A) Cells were loaded with 5 μmol/l of Fluo-4 AM, and a 10 × 10 μm of cell surface was scanned with the SICM. The nanopipette was positioned above a crest or a groove as identified on the scan and, while keeping the distance constant at 200 nm, positive air pressure was applied to the auxiliary port of the pipette holder, generating a hydrojet pressure. A protocol written on Clampfit 10.0 (Molecular Devices) synchronized the light shutter for optical acquisition (8 s in total at 1–5 KHz temporal acquisition) and the pump for pressure application (ramp duration 2 s at 20 kPa). Fluo-4 fluorescence emission was recorded (represented as a color-coded time-lapse map) together with the Z-piezo displacement (corresponding to membrane indentation) and the mechanically induced calcium initiation and propagation. Typical readings of pressure, Z-piezo displacement, and calcium transient are represented on the right.
(B) Perturbed area following 20 kPa ramp hydrojet pressure (2 s) in an isolated cardiomyocyte. Pipette solution was filled with 1 μM Lucifer yellow, resulting in ∼0.125 μm2 area (green spot), enlarged in the inset.
The scale bar represents 10 μm in (A) and 500 nm in the inset.
Results
Structural and Mechanical Properties of Failing Cardiomyocytes
We scanned the structural features of the sarcolemma of normal and failing cardiomyocytes (mainly from compensatory hypertrophy, derived from zones remote from the scar) using SICM at different time points following myocardial infarction (MI). Then, we positioned the pipette at 200 nm over a pre-selected site on the sarcolemma (either a crest or a Z-groove or an area without structure) chosen on a previously acquired topography image (Figure 1A). Subsequently, we applied a localized 20-kPa hydrojet for 2 s. The area indented by the hydrojet (Figure 1B) is in the range of 0.125 μm2.We studied rat cardiomyocytes following MI, progressing toward heart failure. They developed heart failure in our model at 16 weeks with clear evidence of hypertrophy and left ventricular failure (Table S1). We first obtained a 10 × 10 μm SICM topographical image of a normal or a failing cardiomyocyte (Figure 2A). These scanned topographical images were used to quantify disruption of surface structural regularity; the images showed that cells progressively change their sarcolemmal regularity (Figure 2A). We measured the Z-groove index, as previously reported (Lyon et al., 2009, Lyon et al., 2012), which reduced significantly from 0.62 ± 0.16 in control cardiomyocytes to 0.44 ± 0.19 in cells 16 weeks post-MI (p < 0.05; Figure 2B). Membrane organization is substantially altered following MI, including the disappearance of crests and grooves.
Figure 2
MiCai Propagation Changes from Local to General during Progression to Heart Failure
(A) (Upper left) Surface topography of an AMC cardiomyocyte (10 × 10 μm). (Upper right) Surface topography of a heart failure cardiomyocyte (10 × 10 μm) at 4 weeks post-myocardial infarction (MI_4wks) is shown. (Lower left) MI_8wks surface topography is shown. (Lower right) MI_16wks surface topography is shown.
(B) Frequency of MiCai propagation during progression to heart failure at AMC, 4–8, and 16 weeks post-MI, respectively.
(C) Z-groove index calculated for AMC cells and heart failure cells at 4, 8, and 16 weeks post-MI (n = 6 each; mean ± SEM; ∗p < 0.0005).
(D) Membrane compliance calculated after 20 kPa hydrojet square pulse pressure applied for 2 s at crests, Z-grooves, or un-striated parts of the cells. Pipette-tip diameter 200 nm; n: approximately 20 cells each group; n = 71 in total; mean ± SEM; ∗p < 0.05; ∗∗p < 0.001.
To study the mechanical properties of the cell surface microdomains, we then applied pressurized hydrojet ramps within the range 0–40 kPa (typically 20 kPa) for 2 s either over a smooth or grooved area of the cell and recorded pipette vertical displacement. As the pipette, driven by the SICM’s feedback control mechanism, follows the cell surface under the pipette, we essentially recorded membrane displacement (Z) as a function of applied pressure. In normal cells, the areas around grooves are stiffer than the crests, as less pipette displacement was observed for the same pressure applied. However, failing cells have uniformly stiff membranes, regardless of the area (Figure 2D).During progressive heart failure, we found that, at 4 weeks after MI, the surface regularity begins to change, but not significantly (Figures 2A and 2C). However, membrane compliance has already reduced significantly in all areas of the sarcolemma (Figure 2D). At 8 weeks, structure is gradually lost and the membrane is stiffer than in control cells. The membrane compliance data following hydrojet application have been previously used to calculate Young’s modulus of elasticity in living cells (Sánchez et al., 2008). We found, similarly, that the modulus varies considerably across the myocyte surface (crest: 0.038 ± 0.003 μm/kPa versus groove: 0.009 ± 0.001 μm/kPa in control cardiomyocytes; Figure 2D).
MiCai in Failing Cardiomyocytes
In healthy control cardiomyocytes, pressure applied in a Z-groove initiates a focal MiCai, which is characterized by relatively slow propagation and is spatially restricted to the pressure site (Figure 3A, left). In contrast, in failing cardiomyocytes, MiCai initiates at the pressure site and propagates throughout the whole cell (Figure 3A, right). The MiCai wave spreads more rapidly in failing cells (lower time to peak; Figure 3B), as control cardiomyocytes displayed mainly localized MiCai, with the total time to peak of 252.4 ± 11 ms, whereas failing myocytes have mainly propagated MiCai with a time to peak of 134 ± 26 ms (Figure 3B). We studied MiCai characteristics and kinetics. MiCai events in failing cells have a longer duration and higher amplitude than in control cardiomyocytes (Figure 3B). As cells remodel following MI and progress toward heart failure, the probability and frequency of MiCai propagation increases. At 4 weeks after MI, the propagated MiCai occurs only marginally more frequently than in control cells, whereas at 8 weeks, the propagation manifests more often after a hydrojet (Figure 2B).
Figure 3
MiCai Propagation Changes from Local to General during Progression to Heart Failure
(A) Color-coded propagation time maps of MiCai in an AMC (focal propagation; left panel) and a failing cardiomyocyte 16 weeks post-MI (whole-cell propagation; right panel). The scale bar represents 10 μm.
(B) Mechanically induced calcium transient (MiCai) parameters (time-to-peak, duration, and amplitude; mean ± SEM) in AMC cells when the pressure was applied either to a crest or to a groove and in heart failure cells to unstructured areas; n = 10 each.
(C) Frequency of MiCai in AMC cells at baseline (upper left), in the presence of caffeine (upper right), nifedipine (lower left), CCCP (lower middle), and CsA (lower right); n = 14. n.s., not significant; p = 0.0005 (MI-16wks); Fisher exact test; multiple contingency.
Generally, failing cardiomyocytes show two different patterns of MiCai initiation and propagation (Figure S1; Movie S1). One is the appearance of a solitary “ripple” starting underneath the pressure site and slowly propagating throughout the cell (Figure S1A, left panel); this single initiation occurs at all time points at 4, 8, and 16 weeks post-MI (Figure S1B). The other initiation is more complex (Figure S1A, right panel) with the MiCai ripple starting underneath the pressure site, but after ∼1 or 2 ms, an additional remote MiCai signal or signals (binary emergence) from the cell periphery follows the initial wave. The latter triplet Ca2+ wave fronts collide and propagate rapidly throughout the cell (Figure S1B; Movie S2).
MiCai Initiation Is Independent of L-type Calcium Channels, Sarcoplasmic Reticulum, Stretch-Activated Channels, or Actin Cytoskeleton
The prime source of the initial calcium release in the cytoplasm during myocyte contraction is L-type calcium channels (LTCCs) (Santulli and Marks, 2015). To explore the involvement of LTCCs and ryanodine receptors (RyR2) in the initiation of MiCai, we varied Ca2+ concentration in the extracellular HBSS solution from zero, to low (0.1 μmol/l), to “physiological” (1.8 μmol/l). This doesn’t influence the frequency of MiCai (data not shown). Nifedipine also failed to stop MiCai occurring (Figure 3C, bottom left panel). We then sought to explore the mechanosensing role of sarcoplasmic reticulum and the role of the RyR2 by analyzing the effect of caffeine on the frequency of MiCai events. Although high-dose caffeine opens RyR2 (Dobrev and Wehrens, 2014), it doesn’t alter the frequency of propagated MiCai in both normal and failing cells (Figure 3C, top panels). We subsequently checked other potential mechanosensors that could trigger a MiCai initiation. As hydrojet indents and therefore stretches the membrane, we inhibited stretch-activated channels with either 100 μmol/l streptomycin (White, 2006) or 30 μmol/l gadolinium (Gd3+) (Ermakov et al., 2010; Figure S3A; Movie S3). This failed to abolish MiCai initiation under the pressure site, suggesting that the main local mechanosensors are not stretch-activated channels related (Figure S3B). We focused on the cytoskeleton, as many proteins at the costamere are actin-binding mechanosensing proteins (Ingber, 1997). Disrupting actin microfilaments in AMC cells with 5 μmol/l cytochalasin D, for 2 hr (Undrovinas and Maltsev, 1998), stiffened the cardiomyocyte sarcolemma and blocked contraction but did not alter MiCai events incidence or Z-groove ratio (data not shown).
Mitochondria Re-alignment during Heart Failure Is Related to Triggering MiCai
The lack of involvement of extracellular calcium indicates the existence of an intracellular Ca2+ source, and having excluded the sarcoplasmic reticulum, we needed to find another source. The involvement of mitochondria in pressure-induced intracellular Ca2+ release has been demonstrated previously (Belmonte and Morad, 2008a), so we employed both confocal microscopy in combination with SICM (SSCM) and transmission electron microscopy (TEM) to investigate the sub-membrane interaction between dyads and mitochondria in failing cells. In normal control cardiomyocytes, active TMRM-labeled mitochondria align with crests with a periodic arrangement, which reflects regular arrangement of Z-grooves and T-tubule openings (Figures 4, particularly shown in the TEM panel, and S2A). Heart failure cells lose this regularity of mitochondria organization; it also seems that mitochondria elongate (Figure 4, right panels) and become less fragmented (Figure S2B) and the average area of mitochondria increases (Figures S6A, S6B, and S6D). Then, we inhibited the mitochondrial proton gradient and the permeability transition pore with CCCP and cyclosporinA (CsA), respectively, and, in contrast to previous pharmacological treatments described in the previous chapter, we found that this treatment abolishes the propagating MiCai in failing cells. This indicates an active role of mitochondria in this process (Figure 3C, bottom two right panels). These observations suggest a correlation of mitochondria derangement with the occurrence of propagated MiCai and indicate a possible active role of remodeled mitochondria microdomains in MiCai initiation.
Figure 4
Myocardial-Infarction-Induced Remodeling of Dyad Microdomains Is Characterized by a Mitochondrial Shift
(Left column) Control (AMC) cells; (right column) heart-failure-derived cells (16 weeks post-MI). (Top row) SICM surface topography is shown; (next row down) TMRM-labeled mitochondria are shown; (next row down) merged images of SICM cell topography and surface confocal (10 × 10 μm) are shown; and (bottom row) representative transmission electron micrographs, illustrating the reorganization of mitochondria in heart failure, are shown.
Microtubular Network Derangement Is Responsible for Mitochondrial Displacement
Recently, a microtubular role for MiCai and Ca2+i spark generation has been proposed (Prosser et al., 2013, Iribe et al., 2009). We wanted to test this on our model and disturbed microtubular polymerization with 10 μmol/l colchicine (Iribe et al., 2009; Figure 5). Colchicine didn’t affect either the surface Z-groove architecture (Z-groove index; 0.61 ± 0.04 pre- versus 0.63 ± 0.05 post-treatment; p = ns; Figures S4A and S4B) or the T-tubular density (Figures S4C and S4D, left). However, both colchicine and nocodazole treatment significantly reduced T-tubule regularity (Figures S4C and S4D, right) and membrane compliance (Table S2). Having applied colchicine, we then investigated the frequency of propagated MiCai with respect to location of the applied hydrojet pressure. Hydrojets applied to the crest of colchicine-treated cells initiated MiCai in 69% of cases versus 12% in control AMC cells, i.e., without colchicine (Figure 5A). However, either combined colchicine plus CCCP (Figure 5C) or colchicine plus CsA (Figure S5A) treatments abolish this effect completely. Confocal and TEM microscopy show that colchicine displaces sub-sarcolemmal mitochondria in controls (Figure 5B, right panel) and the average mitochondrial area is increased, which makes them similar to the heart failure cells (Figures S6A, S6C, and S6D). Even in normal cells, colchicine stiffens the membrane (Figure 5D) and produces a similar membrane compliance to that seen in heart failure. This suggests that microtubular network dysregulation shifts the mitochondria, and that is the proposed critical mechanism underlying susceptibility to MiCai.
Figure 5
Disruption of Microtubules Leads to a More-Frequent MiCai
(A) Time-lapse color-coded maps of MiCai. (Top row) 20 kPa hydrojet pressure applied to the center of an AMC myocyte produces no MiCai; (bottom row) the same cell after exposure to 10 μmol/l colchicine for 1 hr at 36°C shows a propagated MiCai after the same pressure has been applied to the same spot. The scale bar represents 10 μm.
(B) Membrane staining of T-tubules (green; Di-8-ANNEPS) and immunostaining for β-tubulin (red) in an AMC cardiomyocyte (left panels) and an AMC cardiomyocyte incubated with colchicine for 1 hr in 36°C (right panels). The scale bar represents 10 μm. (Rightmost picture) Electron micrograph shows mitochondrial movement following incubation of an AMC cell with colchicine (10 μmol/l for 1 hr). The scale bar represents 1 μm. Mit, mitochondria.
(C) Frequency of propagated MiCai that occur in AMC cells treated with colchicine and with colchicine in combination with CCCP. n = 12 AMC; n = 21 colchicine; n = 10 colchicine+CCCP. p = 0.0005; Fisher exact test; multiple contingency.
(D) Membrane compliance of crests and grooves in AMC treated with colchicine and CCCP. n = 21 per group; ∗∗p < 0.001.
Previously, β-tubulin has been found to largely co-localize with cytoplasmic organelles, including mitochondria (Saetersdal et al., 1990). We therefore sought to investigate, in colchicine-treated cells, the relationship between the mitochondrial shift with its re-positioning and the microtubular derangement. Immunocytochemical analysis demonstrated that colchicine significantly disrupted cardiomyocyte β-tubulin in both AMC cells (Figure 5B) and heart failure cells (Figure S6C). Supporting the notion that the tubulin network is distorted in heart failure cells, mRNA expression analysis by qPCR confirmed an overall increase in the expression of α1A-tubulin (TUBA1A), β2B-tubulin (TUBB2B), β3-tubulin (TUBB3), γ-1tubulin (TUBG1), and microtubule-associated proteins (MAP4; Figure S6D). These are known to be associated with altered microtubular dynamics (Roos et al., 2002). Interestingly, entirely disrupting the microtubular network in failing cardiomyocytes (colchicine administration) did not abolish MiCai (Figure S7D) and significantly affected the membrane compliance (Figure S7C).
MiCai in Human Failing DCM Cells
We investigated the MiCai incidence in human cardiomyocytes from dilated cardiomyopathy (DCM) patients. First, SICM imaging revealed a topographical heterogeneity (Figure 6A) similar to that previously seen in failing rat cardiomyocytes (Lyon et al., 2009). Propagating MiCai (Figures 6B and 6C) occurred in 65% of all pressure applications, mainly when pressure was applied over non-striated, stiffer areas (Figure 6D), mimicking the rat heart failure model. Similarly to the rat failing cells, we found that, in human DCM cells, α1C-tubulin (TUBA1C), β2A-tubulin (TUBB2A), TUBB3, TUBG1, and MAP4 were significantly upregulated as compared to non-failing cardiomyocytes, suggesting a primary role for microtubule disruption in cellular vulnerability to MiCai generation (Figure 6E).
Figure 6
MiCai Occurrence in Human DCM Cardiomyocytes
(A) Membrane topography of a human heart failure cardiomyocyte (10 × 10 μm).
(B) (Left-hand side) color-coded time-lapse map of MiCai propagation. The scale bar represents 10 μm.
(C) Fluorescence trace of MiCai.
(D) Frequency of propagated MiCai in human heart failure cells.
(E) Microtubule protein mRNA is upregulated in DCM cardiomyocytes as compared to non-failing human cardiomyocyte. Technical triplicate normalized to 18 s is shown. mRNA quantities are presented as mean ± SEM (∗∗p < 0.01); n = 7.
Discussion
We report that a nanoscale perturbation of the surface membrane of control (AMC) and failing cardiomyocytes can elicit mitochondria-dependent Ca2+ release within milliseconds. This MiCai is locally constrained and non-propagating. Sarcolemmal structural organization together with sub-sarcolemmal mitochondria regularity and high membrane compliance are prerequisite for impeding the MiCai propagation (Figure 7; summarized in Table S2).
Figure 7
Schematic Representation of the Proposed Mechanisms of MiCai Propagation
(A) Normal conditions. The interplay of an organized microtubular network, regular T-tubule membrane structure, and sub-sarcolemmal mitochondrial alignment protects against MiCai propagation by providing tight control of calcium levels. MIT, mitochondria; SR, sarcoplasmic reticulum.
(B) Heart failure conditions. Overexpression and remodeling of microtubules together with mitochondrial delocalization and loss-of-membrane structural regularity enable MiCai propagation due to loss of appropriate control.
Mitochondria Implication in Mechanically Induced Calcium Initiation in Failing Cells
In healthy ventricular cardiomyocytes, sub-sarcolemmal mitochondria are arranged periodically under crests, separated by similarly periodic T-tubules. We suggest that this facilitates tight signal regulation with feedback loops close by, preventing calcium propagation along the sub-sarcolemma. The SICM distinguished crests and grooves on the surface of cardiomyocytes, and the same scanning nanopipette delivered hydrojets selectively to a nanoscaled area without damaging the membrane. This precise mechanical stimulation elicits a MiCai, which is normally constrained locally. In failing cardiomyocytes where the striations are progressively lost, particularly at 16 weeks post-MI, pressure application to a non-striated region triggered a propagated MiCai. Regular mitochondrial arrangement is lost in heart failure or experimentally induced microtubule derangement, implying that the microtubular network regulates the structural arrangement, with loss leading to altered restriction of membrane-perturbation-triggered MiCai, with a relatively large, propagating, expansive calcium response from mitochondria. Decreased membrane compliance is a prerequisite for eliciting MiCai. In heart failure, the membrane is stiffer, and this increases the likelihood of MiCai (Borbély et al., 2005).The mechanism implicates mitochondria, which are normally aligned under the crests and sense our applied force (in both non-failing and failing cells; Figure 7). Microtubules are pivotal in maintaining ordinary mitochondrial cytoarchitecture and in supporting physiological cellular membrane compliance.
Under Physiological Conditions, Higher Membrane Compliance Attenuates Forces Transmitted to the Mitochondria
We propose here that, in normal physiological conditions, higher membrane compliance (softer membrane) absorbs, attenuates, and buffers the forces transmitted to the mitochondria, whereas in heart failure cells, with microtubular derangement, lower membrane compliance (stiffer membrane) allows rapid force transmission to subcellular microdomains, which involve elongated and displaced mitochondria. The experimental data suggest that the remodeled mitochondria in failing cells are more sensitive to pressure changes within their microenvironment, producing an abnormal mitochondria Ca2+ release, which in turn triggers the calcium initiation and its propagation cascade. In line with this hypothesis, we show that pharmacological uncoupling of mitochondrial metabolism with CCCP abolishes MiCai generation mainly because we introduce a break in the intracellular Ca2+-driving source that can be mechanically activated via microtubular force transmission.
Mechanical Stimulation of Failing Cardiomyocytes Generates Multiple MiCai
In more-advanced stages of pathological remodeling 8–16 weeks following MI, we observed the generation of a second “ectopic” calcium wave that arises from remote regions of the cell. One plausible explanation is related to cross-bridge cycling. The local sarcomere contraction underneath the pressure site’s MiCai relaxes while more-distant sarcomeres contract, shortening against the lower compliance of the relaxing region. The shortening of these distant sarcomeres releases Ca2+ from its cycling troponin (Lab et al., 1984, ter Keurs et al., 2001) into the sarcoplasm. This could manifest as the remote peripheral Ca2+ signal. The other mechanism is that the stiffer sarcolemma transmits pressure to remote stretch-activated channels to admit calcium. Indeed, streptomycin or Gd3+ (selective blockers of stretch-activated channels) abolished this peripheral activation. Further investigations should provide further insight.MiCai propagation occurs in a single ripple initiation underneath the hydrojet pressure site. None of the following, stretch-activated channels inhibition by either streptomycin or Gd3+ or actin disruption with cytochalasin D, blocked both the initial MiCai signal and its propagation. In fact, 1 hr of cytochalasin D treatment in failing cells actually augments membrane stiffness and, by disrupting actin calcium-binding sites, abolishes contraction, despite leaving MiCai initiation unaffected.
Microtubular Network Derangement Is a Prerequisite for MiCai Propagation
Recent studies have implicated X-ROS signaling in inducing Ca2+ release (independently from mitochondria) by stretching the cell (Prosser et al., 2011). However, this activation required an intact microtubule network, which is supported by the observation that an increase in the microtubule network density (e.g., Duchenne muscular dystrophy; Prosser et al., 2013) decreases X-ROS signaling. We found that pharmacologically induced microtubular depolymerization in control cells produces a similar functional phenotype as that in heart failure cells, i.e., reduces membrane compliance and raises the likelihood of MiCai propagation, which we see in 69% of cases (Figure 5A). Moreover, our intracellular findings agree with a large animal study, where colchicine exacerbated chest-impact-induced ventricular fibrillation (commotio cordis; Link et al., 1998). Upregulation of microtubular proteins encountered during heart failure (Roos et al., 2002) are implicated in destabilizing the microtubules network, by affecting T-tubule density and regularity. Disruption of the microtubule network allowed spreading of the normally constrained MiCai, mimicking the pattern of MiCai propagation observed in failing cardiomyocytes. Mitochondria and microtubules are in intimate contact at sub-sarcolemmal levels because β-tubulin is confined to the perinuclear and inter-fibrillar spaces and is largely co-localized with the cytoplasmic organelles (Saetersdal et al., 1990). In cardiomyocytes, the distribution of β-tubulin-2 (Kuznetsov et al., 2013) is restricted to the outer mitochondrial-containing domain that binds to the outer mitochondrial membrane, and this probably also involves microtubular-based trans-locators and/or MAPs.
Sources of Calcium, Such as LTCCs and Sarcoplasmic Reticulum, Are Not Involved in MiCai Generation
We did not find evidence that either extracellular calcium influx mediated by LTCCs or intracellular calcium from sarcoplasmic reticulum are important for mechanosensitive MiCai generation and propagation. However, we cannot exclude that, after the initial calcium has been released from mitochondria, the additional calcium needed to produce a Ca2+ transient is released from the sarcoplasmic reticulum. This is because, in our experiments, we cannot fully deplete the sarcoplasmic reticulum of calcium, nor do we take into account the sarcoplasmic reticulum leak that loads the mitochondria with calcium (Santulli and Marks, 2015). However, mechanical stimulation may trigger a relatively small mitochondrial Ca2+ release to produce the sarcoplasmic reticulum Ca2+ release. This is because we still observe the MiCai in low [Ca2+] solution.
Mitochondria re-locate from the crest during heart failure; the microtubule network disorganization modifies the mitochondria-crest interface and manifests as a reduction in the membrane compliance and decreased dyad regularity. Mitochondria relocation during heart failure, accompanied with increase in membrane stiffness, was recently described and investigated using atomic force microscopy (Dague et al., 2014). This study complements our data with our contact-free SICM and supports myocardial remodeling (with increasing average mitochondrial areas) with microtubular network derangement as crucial in the initiation of MiCai. Pressure-induced calcium release in a single cell is not a physiological issue as arrhythmia is a multicellular phenomenon; however, our proof of concept indicates microdomains disarray as an important mechanism. This, together with sarcomeric dyssynchrony in heart failure (Sachse et al., 2012), can lead to mechanically driven pathological consequences. Future challenges will be to investigate whether similar mechanisms are implicated in other cardiovascular pathologies such as hypertensive or ischemic heart disease.Nonetheless, our observations have a potential translational element. Cellular heterogeneity flourishes in heart failure, and the mechanically induced calcium changes have electrophysiological consequences that are potentially arrhythmogenic. Approximately 15% of MI patients die from sustained ventricular tachycardia and fibrillation in the first 2 years after first hospitalization (Bloch Thomsen et al., 2010). The mechanisms we propose here can be included in the “maladaptive electrical and mechanical remodeling,” known to ultimately predispose the heart to arrhythmias by, for example., inducing calcium-overload-related triggered activity (Adamson et al., 2005, Wasson et al., 2004).
Conclusions
In summary, our combination of SICM and optical mapping of mechanically induced impulse propagation in a single cell is able to identify and localize functional mechanosensing with nanometer precision in live cells in general and, in particular, cardiomyocytes. We propose that, in heart-failure-derived cardiomyocytes, highly localized nanomechanical stress via their stiffer membranes and disrupted microtubule networks can trigger localized mitochondrial-dependent Ca2+ release, which initiates cell-wide Ca2+ wave propagation. As intracellular Ca2+ waves contribute to arrhythmogenesis on multicellular scales, the mechanisms we describe may represent an arrhythmogenic substrate for ectopic initiation and propagation. This not only provides mechanistic insights, it also provides new therapeutic targets. Moreover, changes in membrane compliance, which facilitate force transmission enabling calcium changes, could be a potential clinical marker.
Experimental Procedures
Rat Cardiomyocytes Isolation
All animal surgical procedures and perioperative management conformed to the UK Animals (Scientific Procedures) Act 1986 of the Imperial College London Ethical Review Committee. The project license authorized these studies in accordance with the United Kingdom Home Office Animals (Scientific Procedures) Act 1986. Adult male Sprague-Dawley rats (250–300 g) underwent proximal left anterior descending coronary ligation to induce chronic MI as described previously (Lyon et al., 2009; see Supplemental Information for details). Only cardiomyocytes from ventricular zones remote from the scar were utilized for the experiments.
Human Cardiomyocytes Isolation
Human myocardium was obtained from explanted hearts of patients with DCM undergoing cardiac transplantation with the approval from Bromton Harefield and NHLI Research Ethic Committee (ref 01-194). Human cardiomyocytes were isolated, macerating tissue and incubating sequentially in low-calcium- and collagenase/protease-containing solutions as described previously (del Monte et al., 1999).
In Vivo Cardiac Function
Cardiac function was assessed via biometrics and echocardiography. Heart weight corrected to tibia length provided a measure of hypertrophy. Echocardiography was performed under general anesthesia (2% isoflurane) immediately prior to dispatch to give a measure of in vivo cardiac function. The imaging was performed in M-mode in the parasternal long axis view (Table S1; Vevo 770 system). After 4, 8, or 16 weeks following coronary ligation, rats were dispatched by cervical dislocation after brief exposure to 5% isoflurane until the righting reflex was lost. We perfused the left ventricle via the Langendorff perfusion apparatus (Sato et al., 2005). Cardiomyocytes were enzymatically isolated from the left ventricle.
Customization of Hopping Probe SICM and Optical Mapping of Impulse Propagation
The SICM setup has been previously described (Miragoli et al., 2011), as has its application in the hopping mode (Novak et al., 2009). We combined this system with a fast, high-resolution optical camera (Ultima-Scimedia) mounted on an inverted microscope. This was focused upon the membrane region subtending the scanning pipette of the SICM (Figure 1). Briefly, a piezo-controller (ICnano Scanner Controller; Ionscope) controlled the xyz piezo three-axis translation stage Triton-100 (Piezosystem) with 80-μm closed-loop travel range in x, y, and z directions. The piezo stage was driven by high-voltage amplifier System ENV 150 (Piezosystem) connected to ICnano scanner controller. The pipette electrode head stage was connected to Multiclamp 700B (Molecular Devices). The scan head was placed on the platform of Nikon TE-i inverted microscope (Nikon Corporation). Nanopipettes (∼25–100 MΩ tip resistance) were pulled from borosilicate glass (O.D. 1.0 mm; I.D. 0.58 mm; Intracell) using a laser puller (P-2000; Sutter) The pipettes were filled with Hanks’ balanced salt solution (HBSS) and utilized to acquire SICM images of membrane topography. These were utilized for all the hydrojet pressure-application experiments (see Supplemental Information for details).
Hydrojet Pressure Application
A square pulse or ramp (depending on the experiment) of air pressure delivered by displacing air connected to the auxiliary inlet in the pipette holder generated a hydrojet of the intracellular pipette solution (HBSS); the delivery was controlled by an electric valve via Digidata 1440A (Molecular Devices). We choose 20 kPa for a square pulse pressure, resulting in a perturbation of ∼0.125 μm2 area within the sarcomere. Membrane compliance was derived from the nanopipette’s vertical displacement (Z-direction), acquired using pClamp 10.0 (Molecular Devices). The volumetric flow rate and the hydrojet velocity were calculated as previously described (Sánchez et al., 2008).
Surface Confocal SICM Study of Mitochondria
We imaged mitochondria in control cells and those 16 weeks post-MI. Cells were stained with the fluorescent tetramethylrhodamine methyl ester (TMRM) dye (mitochondrial membrane potential dye) for 10 min at 37°C (100 nmol/l). TMRM was excited at 532 nm with a MLL532 20-mV laser (Changchun New Industries Optoelectronics Tech), and confocal images were taken at 100× magnification using a Photomultiplier Detection System (PTI). We aligned the laser beam with the tip of the pipette, then we scanned the cell surface with the SICM to obtain a topographical image, and finally we re-scanned the same area with the confocal laser beam to visualize the mitochondria. The two resulting images were overlaid to co-localize the mitochondria with cellular topography.
Optical Mapping of Intracellular Impulse Propagation
After isolation, cardiomyocytes were seeded onto 22-mm coverslips, loaded with 5 μmol/l Fluo-4 AM (Invitrogen) as an intracellular [Ca2+]i transient indicator and incubated for 20 min at 35°C, 5% CO2 before mounting on a customized perfusion chamber. [Ca2+]i transients were acquired at 1–10 kHz sample resolution at 36°C, using a 40× objective with a fast resolution CMOS camera (Ultima; Scimedia) and dedicated acquisition software (MiCam Brainvision). A dedicated piece of software (Brainvision Ana v. 1208) was utilized to determine intracellular calcium propagation.
Synchronization of the Acquisition
A protocol written in pClamp 10.0 was used to synchronize the pressure application and the optical calcium recording via Digidata 1440A (Molecular Devices). It synchronized triggering the open/closed states of the electric valve (2 s; square pulse) and the light shutter (Uniblitz; Vincent Associated). Each recording lasted 8 s.
Drug Dilutions
Caffeine (10 mmol/l), colchicine (10 μmol/l), nocodazole (4 μg/ml), streptomycin (100 μmol/l), nifedipine (2 μmol/l), carbonyl cyanide m-chlorophenyl hydrazine (CCCP) (0.1 μmol/l), and CsA (0.5 μmol/l) were dissolved in HBSS containing (in mmol/l) NaCl (144), HEPES (10), MgCl2 (1), and KCl (5; 0.1 mmol/l CaCl2 for CCCP and colchicine experiments). Cytochalasin D was dissolved in DMSO and diluted in HBSS. Gadolinium (Gd3+) was dissolved in miliQ water and diluted to 30 μM in HBSS immediately before use (Yeung et al., 2003).
T-Tubule Density and Regularity Measurements
Left ventricle cardiomyocytes were derived from control animals and those 16 weeks post-MI. Cells were stained with the fluorescent dye Di-8-ANEPPS (10 μmol/l) for 1 min. Di-8-ANEPPS was excited at a wavelength of 488 nm, and confocal z-stacked images were taken at 63× magnification using a LSM-780 inverted confocal microscope (Zeiss). The resulting images of the T-tubule network were analyzed using the freeware ImageJ (http://rsbweb.nih.gov/ij/) by randomly choosing two separate areas of 40 × 5 microns. The chosen areas were converted into binarized black and white images and then plotted into waveforms. The binarized versions of the confocal images were used to define the T-tubule density by calculating the ratio of black to white pixels in each chosen area whereas the waveforms were transformed into power-frequency peaks through a 1D Fourier transformation using a custom-written macro for the software Matlab (The MathWorks). The amplitudes of the calculated peaks were plotted as T-tubule regularity and were interpreted as an indicator of how regular T-tubules appear.
Confocal Microscopy Images of Mitochondria and T-Tubules
Control cells (AMC), MI-16 weeks, and AMC cells treated with colchicine were stained as previously described with TMRM and DI-8-ANEPPS. Confocal z-stacked images were taken at 63× magnification using a Zeiss LSM-780 inverted confocal microscope. The AMC cells were treated with colchicine (10 μmol/l) for 3 hr as known to be adequate for the selective disruption of microtubules (White, 2011). The resultant images of the T-tubule network and mitochondria were overlaid using the freeware ImageJ software.
Analysis of Confocal Microscopy Images of Mitochondria
The resulting images of the mitochondria were analyzed using the freeware program ImageJ (http://rsbweb.nih.gov/ij/) with a mitochondrial morphology plugin (Dagda et al., 2009). Three slices from the z stack were analyzed for each cell to obtain an average area of the mitochondria elements per cell. In brief, after selecting the area of the cell to be analyzed, avoiding the edge of the cells, the image is binarized, and the plugin measures the area for each single element (single mitochondria and cluster of mitochondria).
Data Statistics
All data are described as mean ± SEM for the given number of experiments. Significance was calculated using Student’s t test and Fisher exact tests and is indicated in the figure legends.
Author Contributions
M.M., M.J.L., and J.G. initiated the study. M.M. performed all the pressure application, optical mapping, and membrane compliance experiments and analyzed the data associated with it. J.L.S.-A. conducted the SICM surface confocal and the TMRM confocal images and analyzed the data associated with it. I.D. performed the TEM and the tubulin staining and analyzed the data associated with it. A.B. conducted the SICM experiments of cardiomyocytes and z-groove calculations. P.T.W. isolated the human cardiomyocytes. M.S. and A.R.L. generated the heart failure model. S.S. performed the TT density and regularity measurements. P.N. helped with SICM adaptation for membrane compliance. A.C. and P.C. performed the mRNA studies. M.M., J.G., and M.J.L. conceived and designed research, performed data analysis, and wrote the manuscript. All authors discussed and contributed to the manuscript.
Authors: Frank B Sachse; Natalia S Torres; Eleonora Savio-Galimberti; Takeshi Aiba; David A Kass; Gordon F Tomaselli; John H Bridge Journal: Circ Res Date: 2012-01-17 Impact factor: 17.367
Authors: Benjamin L Prosser; Ramzi J Khairallah; Andrew P Ziman; Christopher W Ward; W J Lederer Journal: J Mol Cell Cardiol Date: 2012-12-06 Impact factor: 5.000
Authors: Alexander R Lyon; Viacheslav O Nikolaev; Michele Miragoli; Markus B Sikkel; Helen Paur; Ludovic Benard; Jean-Sebastien Hulot; Erik Kohlbrenner; Roger J Hajjar; Nicholas S Peters; Yuri E Korchev; Ken T Macleod; Sian E Harding; Julia Gorelik Journal: Circ Heart Fail Date: 2012-03-28 Impact factor: 8.790
Authors: M Celeste Ferreira-Cornwell; Yang Luo; Navneet Narula; Jennifer M Lenox; Melanie Lieberman; Glenn L Radice Journal: J Cell Sci Date: 2002-04-15 Impact factor: 5.285
Authors: Michele Miragoli; Alexey Moshkov; Pavel Novak; Andrew Shevchuk; Viacheslav O Nikolaev; Ismail El-Hamamsy; Claire M F Potter; Peter Wright; S H Sheikh Abdul Kadir; Alexander R Lyon; Jane A Mitchell; Adrian H Chester; David Klenerman; Max J Lab; Yuri E Korchev; Sian E Harding; Julia Gorelik Journal: J R Soc Interface Date: 2011-02-16 Impact factor: 4.118
Authors: Davi M Lyra-Leite; Allen M Andres; Andrew P Petersen; Nethika R Ariyasinghe; Nathan Cho; Jezell A Lee; Roberta A Gottlieb; Megan L McCain Journal: Am J Physiol Heart Circ Physiol Date: 2017-07-21 Impact factor: 4.733
Authors: Marta Pérez-Hernández; Alejandra Leo-Macias; Sarah Keegan; Mariam Jouni; Joon-Chul Kim; Esperanza Agullo-Pascual; Sarah Vermij; Mingliang Zhang; Feng-Xia Liang; Paul Burridge; David Fenyo; Eli Rothenberg; Mario Delmar Journal: Circ Res Date: 2020-12-21 Impact factor: 17.367